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IL-34 is overexpressed in the inflamed salivary
glands of patients with Sjo¨gren’s syndrome
and is associated with the local expansion of
pro-inflammatory CD14brightCD16+ monocytes
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Abstract
Objectives. To investigate the expression of IL-34 in labial salivary glands (LSGs) of patients with primary
SS (p-SS) and its role in inducing a pro-inflammatory monocyte phenotype.
Methods. LSG biopsies were obtained from 20 patients with p-SS and 10 patients with non-Sjo¨gren’s
sicca syndrome (n-SS). The expression of IL-34, IL-1b, TNF-a, IL-17 and IL-23 was assessed by real-time
PCR. IL-34 expression was also investigated in LSGs by immunohistochemistry. The frequencies of sub-
populations of CD14+ monocytes were evaluated by flow cytometry among isolated mononuclear cells
from peripheral blood and salivary glands from both patients and controls. The role of recombinant IL-34
on isolated peripheral blood mononuclear cells was also evaluated.
Results. IL-34 m-RNA was overexpressed in the inflamed salivary glands of p-SS and associated with
increased expression of TNF-a, IL-1b, IL-17 and IL-23p19. The increased expression of IL-34 was con-
firmed by immunohistochemistry in paraffin-embedded salivary glands from p-SS patients. IL-34 expres-
sion was accompanied by the expansion of pro-inflammatory CD14brightCD16+ monocytes in the salivary
glands. In vitro stimulation of peripheral blood mononuclear cells with IL-34 induced the expansion of both
CD14+CD16 cells and CD14brightCD16+ cells in p-SS and non-SS subjects.
Conclusion. IL-34 seems to be involved in the pathogenesis of salivary gland inflammation in p-SS.
Key words: interleukin-34, Sjo¨gren’s syndrome, monocytes.
Introduction
Primary SS (p-SS) is a chronic autoimmune disease char-
acterized by keratoconjunctivitis sicca and dryness. The
pathogenesis of p-SS is considered to be multifactorial
[1]. Focal lymphocytic gland infiltration, with up-regulation
of Th1 and Th17 cytokine expression [26] as well as
B-lymphocyte hyperactivity [6, 7] are hallmark character-
istics of the disease. Salivary gland epithelial cells of pa-
tients with p-SS are also thought to play an important
pathogenic role, as suggested by the increased epithelial
expression of several inflammatory cytokines in the histo-
pathological lesions (reviewed in [8]).
IL-34 is a recently described pro-inflammatory cytokine
that specifically and independently, by colony stimulating
factor 1 (CSF-1), binds to the CSF-1 receptor promoting
the phosphorylation of extracellular signal-regulated kin-
ases (ERK)1/2 [9, 10]. IL-34 was originally described as a
cytokine that specifically increases the growth and differ-
entiation of CD14+ monocytes in peripheral blood mono-
nuclear cells (PBMCs) [9].
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IL-34 has also recently been demonstrated to be over-
expressed in the synovial tissue of patients with RA
where, acting as a downstream effector of TNF-a and
IL-1b, it has been found to promote macrophage differen-
tiation and proliferation in synovial tissue, contributing to
inflammation and bone erosions [1113].
Over recent years, several studies have emphasized the
crucial role of monocytes/macrophages in the expansion
and organization of inflammatory infiltrate in several auto-
immune diseases as well as in p-SS [1417]. Different
populations of monocytes have been observed in periph-
eral blood. In particular, based on CD14 and CD16 ex-
pression, human peripheral blood monocytes have been
divided into a major CD14highCD16 population and two
minor CD14brightCD16+ and CD14dimCD16+ subpopula-
tions [18]. These monocyte subpopulations are known to
display distinct phenotypes, functions and behaviour in
inflammatory human diseases. CD14brightCD16+ are con-
sidered pro-inflammatory cells based on the higher ex-
pression of pro-inflammatory cytokines as well as their
ability to promote the expansion of the Th17 cell popula-
tion [19]. Conversely, CD14dimCD16+ monocytes repre-
sent a subset that patrols blood vessels with high
migratory but limited phagocytic potential [20]. Migration
of monocytes in the tissues is driven by cells of connective
tissue origin through the release of chemokines, such as
CSF-1 [21, 22]. The fate of monocytes (whether pro- or
anti-inflammatory) appears to be dependent on a tightly
regulated balance between stromal chemokines and
pro-inflammatory cytokines (such as IL-34), the latter play-
ing an important role in inducing a pro-inflammatory
phenotype.
IL-34 expression and monocyte subpopulations have
not yet been studied in patients with p-SS. The objective
of this study was to investigate the expression of IL-34 in
labial salivary glands (LSGs) of patients with p-SS and its
role in modulating monocyte phenotype.
Patients
Twenty patients with p-SS (18 women and 2 men, median
age 55 years, range 2967 years) diagnosed on the basis
of the AmericanEuropean Consensus Group criteria for
p-SS [23] were consecutively included in the study. The
presence of other underlying autoimmune diseases or
HCV infection was carefully excluded. All patients under-
went serology evaluation that included tests for the pres-
ence of ANAs, anti-SSA/Ro, anti-SSB/La, RF and levels of
CRP and ESR. All patients were naı¨ve to the use of im-
munosuppressive drugs. The clinical characteristics of
these patients are shown in Table 1. Ten patients (all
women, median age 58 years, range 3170 years) with
sicca symptoms who did not fulfil the SS classification
criteria and without histopathological or serological evi-
dence of p-SS were also considered as controls (non-
SS, n-SS). The study was approved by the local hospital
ethics committee (the ethics committee of the AOUP
Paolo Giaccone). Informed patient consent was obtained
from all the patients and controls enrolled.
LSG biopsies
LSG biopsies were obtained, after informed consent, from
p-SS and n-SS, during routine diagnostic procedures.
Biopsy specimens were fixed in 10% buffered formalin
and placed in RNA or RPMI. At least four salivary gland
lobules were used for histological evaluation. Paraffin-
embedded sections stained with haematoxylin and eosin
were studied by the same pathologist (V.R.), using a
microscope equipped with an ocular micrometer.
Evaluation of the presence of lymphocytic infiltrates and/
or foci was performed as previously described [24]. A
focus was defined as an aggregate of 550 lymphocytes.
The focus score was reported as the number of foci per 4
mm2 of tissue, up to a maximum of 12 foci. A biopsy focus
score >1 was observed in all p-SS patients, whereas the
control group invariably displayed a focus score <1.
RNA isolation and quantitative real-time PCR
Salivary gland biopsy specimens were stored in RNAlater
solution (Applied Biosystems, Foster City, CA, USA). Each
sample was lysed in a tissue homogenizer and RNA was
extracted using the commercially available illustra
RNAspin Mini Isolation Kit (GE Healthcare, Little
Chalfont, UK), according to manufacturer’s instructions.
Total RNA was reverse-transcribed to cDNA using the
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystem). Samples were stored at 20C until use.
For quantitative TaqMan real-time PCR, master mix and
TaqMan gene expression assays for glyceraldehyde
3-phosphate dehydrogenase (GAPDH) control for IL-34
(Hs01050926_m1), IL-1b (Hs00174097_m1), TNF-a
(Hs00174128_m1), IL-17 (Hs00174383_m1) and IL-23p19
(Hs00372324_m1) were obtained from Applied
Biosystems. Samples were run in triplicate using the
Step-One Real-Time PCR system (Applied Biosystem).
Relative changes in gene expression between n-SS and
p-SS samples were determined using the Ct method.
Levels of the target transcript were normalized to a
GAPDH endogenous control, constantly expressed in
both groups (Ct ). For Ct values, additional subtrac-
tions were performed between p-SS samples and n-SS
Ct values. Final values were expressed as fold of
induction.
Immunohistochemical staining for IL-34
Tissue samples were fixed in 10% buffered formalin,
dehydrated in ethanol and paraffin-embedded according
to the routine technique. Immunohistochemical analysis
was performed on 3-mm-thick paraffin-embedded sec-
tions as previously described [25]. Briefly, sections were
exposed to rabbit polyclonal anti-IL-34 antibody (Abcam
plc, Cambridge, UK), dilution 1:250, for 1 h at 25C or
unconjugated rabbit immunoglobulins (negative control)
for 1 h at 25C. Staining was detected using the
Novolink Polymer Detection System (Novocastra
Laboratories, Newcastle upon Tyne, UK) according to
the manufacturer’s instructions and counterstained with
aqueous haematoxylin. For the evaluation of IL-34 immu-
noreactions, tissues were examined for evidence of
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staining with the aid of the NIH ImageJ software (http://
rsbweb.nih.gov/ij/), as previously described [25]. Only
ductal epithelial cells were counted regardless of intensity
of staining. For each case, a minimum of 103 cells was
counted; ImageJ software was then able to automatically
generate the percentage of ductal epithelial cells stained
with IL-34 antibody, which was regarded as labelling
index (LI); results were reported as the mean ± S.E.M.
Phenotypic analysis of peripheral blood and tissue
monocytes
Salivary gland tissues from all p-SS and n-SS subjects
were extensively washed in saline buffer and enzymic
digestion was performed using collagenase (1.5 mg/ml;
Life Technologies, Carlsbad, CA, USA) in RPMI-1640
medium (Gibco, Grand Island, NY, USA) supplemented
with 10% inactivated fetal calf serum (FCS, Sigma, St
Louis, MO), 2 mM L-glutamine, 20 nM HEPES and 100 U/
ml penicillin/streptomycin (all four products are from
Euroclone Ltd, UK). PBMCs were isolated from hepari-
nized blood samples from all patients and controls by
Ficoll-Hypaque (Sigma) density-gradient centrifugation.
Cell viability (trypan blue dye exclusion) was always
>95%. Tissue and peripheral blood-derived cells were
stained with the following monoclonal antibodies:
anti-human-CD14-PE, anti-human-CD16-FITC (both from
BD Biosciences, San Jose, CA, USA) and anti-human
cytokeratin (clone MNF116, Dako, Glostrup, Denmark).
Isotype-matched irrelevant antibodies were used as a
negative control. Total cells were incubated with mAbs
for 30 min on ice and washed twice in PBS containing
0.1% (w/v) NaN3. Flow cytometry analysis was performed
using a FACSCalibur (BD Biosciences). At least 50 000
events, gated on the monocyte region, were acquired
for each sample.
Cell cultures with recombinant IL-34
PBMCs isolated from heparinized blood samples of five
p-SS patients and five n-SS by centrifugation over
Ficoll-Hypaque density gradients were evaluated for
CD14 and CD16 expression. Cell suspensions were also
cultured in 24 flat-bottom plate (Becton Dickinson
Labware, Franklin Lakes, NJ, USA) at a density of
1 106 cells in 1 ml of RPMI-1640 medium with 10%
FCS, 2 mM L-glutamine, 20 nM HEPES and 100 U/ml
penicillin/streptomycin with or without recombinant IL-34
(R&D Systems, Minneapolis, MN, USA). Cells were incu-
bated at 37C in a humidified atmosphere containing 5%
CO2. Accordingly to Lin et al. [9], cells were stimulated
with 2 ng/ml of IL-34 and harvested 72 h later, and the
surface expression of CD14 and CD16 on monocytes
was determined by flow cytometry.
Statistical analysis
Analyses were performed using GraphPad Prism software
(version 5.0, GraphPad Software, La Jolla, CA, USA).
Multiple groups were analysed using one-way analysis
of variance and pairwise comparisons using the
MannWhitney U test, with Bonferroni’s correction to
adjust significance levels for multiple comparisons where
appropriate. Correlation analyses were performed using
Spearman’s rank correlation coefficient. P< 0.05 was
considered significant.
Results
IL-34 expression in the salivary glands of p-SS
patients
The expression of IL-34 in the salivary glands from pa-
tients with p-SS and n-SS was assessed by real-time
PCR and immunohistochemistry. By real-time PCR ana-
lysis, we found a significant up-regulation of IL-34 m-RNA
in the inflamed salivary glands of p-SS patients compared
with n-SS (2.5-fold increase, P= 0.0013) (Fig. 1A). The
overexpression of IL-34 was confirmed by immunohisto-
chemical analysis. IL-34 positivity was detected only in
ductal epithelial cells and among infiltrating periductal
mononuclear cells in salivary glands from patients with
p-SS (Fig. 1C and D) compared with n-SS (Fig. 1B).
Staining for IL-34 was not observed in ductal epithelial
cells located in areas without cell infiltrates (data not
shown). No IL-34 expression was observed in the acinar
cells (Fig. 1C and D). In the 30 LSG specimens investi-
gated, the LIs ranged from 0% to 91.3% (mean
41.37 ± 34.19%). Generally, ductal epithelial cells
showed intense cytoplasmatic positivity in p-SS (Fig. 1C
and D), whereas weak cytoplasmic expression was found
in few ductal epithelial cells for only 2 of the 10 controls
(data not shown). No significant differences for the mean
value of IL-34 LIs were found for age or sex (data not
TABLE 1 Baseline characteristic of patients and controls
p-SS (n= 20) n-SS (n= 10) P
Age (years), median (range) 55 (2967) 58 (3170) 0.65
Female sex, n (%) 18 (90) 10 (100) 0.70
Disease duration, months (range) 99 (12240) 88 (18300) 0.44
ANA, % of patients 80  
Anti-Ro and/or anti-LA antibodies, % of patients 58  
RF, % of patients 60  
ESR mm/h, mean (S.D.) 32 (8) 15 (4) <0.001
CRP, mg/l, mean (S.D.) 12 (3) 6 (2) <0.05
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shown). In the patients with p-SS, the IL-34 LIs ranged
from 22.3% to 91.3% (mean 52.64 ± 21.37%) (Fig. 1E),
while in the control group, it ranged from 0% to 18.2%
(mean 3.24 ± 6.81%, P< 0.001) (Fig. 1E). Of relevance,
IL-34 LIs in ductal epithelial cells of LSGs from patients
with p-SS syndrome correlated significantly with the focus
score (r2 = 0.8127, P< 0.0001) (Fig. 1F).
TNF-a and IL-1b were significantly overexpressed and
correlated with IL-34 expression in the salivary glands
of p-SS
It is known that TNF-a and IL-1b up-regulate the expres-
sion of IL-34 [13]. In this regard, we assessed the TNF-a
and IL-1b expression levels by real-time PCR in the saliv-
ary glands of p-SS patients. Both TNF-a and IL-1b were
significantly up-regulated in p-SS compared with n-SS
(3-fold and 2-fold increase, respectively, P< 0.001)
(Fig. 2A and B) and correlated with IL-34 levels (Fig. 2C
and D), suggesting the presence of a local
pro-inflammatory milieu capable of inducing IL-34
expression.
Phenotypic analysis of freshly isolated monocytes
from LSGs and peripheral blood
We next evaluated the behaviour of the different mono-
cyte subsets in the peripheral blood and salivary glands of
p-SS and their relationship with IL-34 expression.
Monocytes isolated from the peripheral blood and LSGs
of patients with p-SS could clearly be divided
into CD14dimCD16+, CD14brightCD16+ and CD14+CD16
populations. Among salivary gland mononuclear cells
from p-SS patients only, the CD14brightCD16+ population
was significantly expanded (12 ± 0.5 vs 6.6 ± 0.6,
P< 0.001) (Fig. 3A, B and E), the expression of CD14
and CD16 never being observed in epithelial cells
(Fig. 3G and H).
The number of CD14brightCD16+ monocytes in the
inflamed salivary glands appeared to be directly corre-
lated with the expression of IL-34, suggesting a role of
IL-34 in the expansion of this monocyte population
(r2= 0.9420, P= 0.006) (data not shown).
Differently from salivary glands, among PBMCs only the
CD14dimCD16+ subset was significantly expanded in p-SS
patients compared with controls (32 ± 1.2 vs 15 ± 1.1,
P< 0.03) (Fig. 3C, D and F). On the other hand, the fre-
quency of circulating CD14brightCD16+ and CD14+CD16
monocytes did not significantly differ between patients
and control subjects (10 ± 1.2 vs 12 ± 1 and 52.8 ± 3.5 vs
60 ± 5.3, respectively) (Fig. 3C, D and F).
IL-34 induces the expansion of CD14brightCD16+
monocytes in isolated PBMCs
IL-34 is known to act as a regulator of monocyte differen-
tiation, proliferation and survival [9], but direct evidence of
IL-34 function on the different monocyte subpopulations
is missing. We investigated, in vitro, the role of IL-34 on
FIG. 1 IL-34 is overexpressed in the salivary glands of patients with p-SS.
(A) Relative expression of IL-34 m-RNA in minor salivary glands of p-SS patients (n= 20), normalized for GAPDH and
plotted as fold of increase over control tissues (n-SS) (n= 20). Results represent the mean ± S.E.M. (BE) Representative
immunostaining of salivary gland biopsies from patients and controls stained with IL-34 antibody in n-SS (B) and p-SS
patients (C and D). Significant staining of IL-34 was observed only in p-SS patients (C and D) (n= 20) compared with
n-SS (n= 10) (B). IL-34 expression was essentially observed in infiltrating mononuclear cells and ductal epithelial cells
(C and D). (E) IL-34 labelling indexes of ductal epithelial cells in p-SS and n-SS. Data are shown as box plots. Each box
represents the 25th75th percentiles. Lines inside the boxes represent the median. Lines outside the boxes represent the
10th and 90th percentiles. (F) Correlation of IL-34 with focus scores. IL-34 expression in ductal epithelial cells by IHC was
correlated with the focus score of minor salivary glands of p-SS. (G and H) Representative sections of n-SS and p-SS
patients stained with control antibody.
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classic monocytes CD14+CD16, CD14brightCD16+ and
CD14dimCD16+. PBMCs from p-SS patients and n-SS cul-
tured with IL-34 significantly expanded classic
CD14+CD16 monocytes (Fig. 4AF). Interestingly, IL-34
stimulation induced a significant reduction of
CD14dimCD16+ cells (Fig. 4AF) and expansion of
CD14brightCD16+ monocytes (Fig. 4AF) in the PBMCs ob-
tained from both p-SS and n-SS, providing evidence for a
role of IL-34 in promoting the differentiation of this subset
of pro-inflammatory monocytes.
Salivary gland expansion of CD14brightCD16+ is cor-
related with IL-23 expression
CD14brightCD16+ monocytes have been demonstrated to
induce a strong Th17 polarization, mainly through the pro-
duction of IL-23 [19]. According to previous reports, both
IL-23 and IL-17 were significantly overexpressed in the
inflamed salivary glands of p-SS (Fig. 5A and B) [5, 24]
and significantly correlated with the expression levels of
IL-34 (Fig. 5C and D).
Discussion
IL-34 is a recently described pro-inflammatory cytokine
that specifically acts on the monocyte/macrophage
system with a functional overlap with M-CSF, inducing
the proliferation of classic CD14+CD16 monocytes [9].
In RA, IL-34 is overexpressed in the inflamed synovium
(where it is correlated with disease severity) and, acting
as a downstream effector of TNF-a and IL-1b, induces
osteoclastogenesis and contributes to tissue inflammation
and bone erosions [11, 12].
SS is a chronic inflammatory autoimmune disease char-
acterized by the disturbance of cytokine networks and the
presence of focal B and T lymphocyte infiltration [26]. A
major involvement of monocytes/macrophages and of
their mediators in the organization of inflammatory infil-
trates has also been hypothesized [1517].
The present study demonstrates that IL-34 is overex-
pressed at m-RNA levels in the salivary glands of patients
with p-SS. Analysis of IL-34 expression by immunohisto-
chemistry confirmed, at protein level, IL-34
overexpression in patients’ salivary glands and showed
a direct correlation between IL-34 expression and the
lymphocytic focus score. IL-34 was expressed exclusively
in the ductal epithelial cells located in areas with cell infil-
trates and in mononuclear cells located within periductal
inflammatory foci. Neither acinar cells nor isolated inflam-
matory cells showed IL-34-positive staining. IL-34
overexpression was correlated with increased salivary
gland expression of IL-1b and TNF-a cytokines and
accompanied by the expansion of CD14brightCD16+
FIG. 2 TNF-a and IL-1b expression in the salivary glands of patients with p-SS.
Relative expression of TNF-a (A) and IL-1b (B) m-RNA in minor salivary glands of p-SS patients (n= 20) normalized for
GAPDH and plotted as fold of increase over control tissues (n-SS) (n= 20). Results represent the mean ± S.E.M. In p-SS
patients, IL-34 expression was significantly correlated with the levels of TNF-a (C) and IL-1b (D).
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monocytes. In in vitro experiments, IL-34 was observed to
expand this subset of pro-inflammatory monocytes.
Monocytes develop initially in the bone marrow and
emigrate into peripheral blood, providing routine
immune surveillance [27]. In humans, peripheral blood
monocytes may be divided into at least two main sub-
sets: a CD14+CD16 monocyte population and, to a
lesser extent, a subset of monocytes that expresses
CD16 with variable expression of CD14 [18].
CD14+CD16+ monocytes are in fact subdivided into two
subpopulations (CD14brightCD16+ and CD14dimCD16+)
according to the level of CD14 expression. These cells
exhibited distinct phenotype and function [18].
CD14dimCD16+ monocytes appear to be essentially
involved in the patrolling of blood vessels and are char-
acterized by high migratory but limited phagocytic poten-
tial [20]. Conversely, CD14brightCD16+ monocytes have
been demonstrated to produce high levels of
pro-inflammatory cytokines [19].
In this study, in agreement with a previous report [28],
we confirm that CD14dimCD16+ monocytes are increased
in the peripheral blood of p-SS and demonstrate for the
first time that salivary glands of p-SS are characterized by
the selective expansion of the CD14brightCD16+ popula-
tion. In contrast to salivary glands, in the peripheral
blood of p-SS patients CD14dimCD16+ predominated.
From the migratory capacity of this subset of monocytes
one might speculate that these cells, having migrated in
the salivary glands of p-SS patients, could differentiate
into the pro-inflammatory CD14brightCD16+ subset under
the stimulation of local specific immunological triggers. In
our study, increased IL-34 expression was correlated with
the expansion of CD14brightCD16+ monocytes, suggesting
that IL-34 may promote a monocytic pro-inflammatory
phenotype. In agreement with this hypothesis, we demon-
strated a significant positive correlation between the
number of CD14brightCD16+ monocytes and the local ex-
pression of IL-34. In this regard, in addition to the
FIG. 3 Monocyte subset percentages in peripheral blood and salivary glands of patients with p-SS and controls (n-SS).
Freshly isolated peripheral blood (PBMC) and salivary gland (SGMC) mononuclear cells from 10 patients with p-SS and
10 n-SS controls were stained with anti-human CD14 and anti-human CD16 monoclonal antibodies and analysed by flow
cytometry. Representative dot-plot analysis of SGMCs from patients (A) and controls (B). Representative dot-plot ana-
lysis of PBMC from patients (C) and controls (D). Percentages of the different monocyte subsets obtained from the
salivary glands (E) and peripheral blood (F) of p-SS patients and controls. (G and H) Representative dot-plot analysis of
SGMCs from patients stained for CD14/CD16 and pan-cytokeratin (as a marker of epithelial cells). The expression of
CD14 (G) and CD16 (H) was never observed among epithelial cells.
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demonstrated expansion of CD14+CD16 monocytes in
response to IL-34 stimulation, in our study IL-34 was
also capable of significantly expanding in vitro the
CD14brightCD16+ monocyte subset. In RA peripheral
blood, CD14brightCD16+ monocytes have been found to
be expanded and to be actively involved in the expansion
of the highly pathogenic Th17 subset of lymphocytes [19].
In our study, salivary gland expansion of CD14brightCD16+
cells was accompanied by increased expression of IL-23
and IL-17, with a direct correlation between IL-23/IL-17
and IL-34 expression, suggesting the existence of an im-
munological link between IL-34 and the IL-23/Th-17 axis
in the salivary glands of p-SS.
In conclusion, the present study provides evidence of
increased IL-34 expression in the inflammatory foci and in
the ductal epithelial cells of inflamed salivary glands of
p-SS. Although functional studies are clearly required to
confirm the role of IL-34 in the pathogenesis of p-SS, the
finding that IL-34 overexpression is accompanied by
salivary gland expansion of the pro-inflammatory
CD14brightCD16+ population of monocytes suggests
a role for IL-34 in the modulation of immune inflammatory
pathways in p-SS.
Rheumatology key messages
. IL-34 seems to be involved in the pathogenesis of
salivary gland inflammation in p-SS.
. IL-34 could be involved in the expansion of a
pro-inflammatory subset of monocytes in the saliv-
ary glands of p-SS.
. Targeting IL-34 represents a potential therapeutic
approach to p-SS.
Funding: This study was supported by a grant from
Ministero della Universita` e della Ricerca Scientifica of
Italy.
Disclosure statement: The authors have declared no con-
flicts of interest.
FIG. 4 Monocyte subset percentages after in vitro incubation of PBMCs of patients with p-SS and controls (n-SS)
with IL-34.
Freshly isolated PBMCs from five patients with p-SS and five n-SS controls were incubated with IL-34 and then stained
with anti-human CD14 and anti-human CD16 monoclonal antibodies and analysed by flow cytometry. Representative
dot-plot analysis of PBMCs obtained from p-SS patients after stimulation with medium (A) or IL-34 (B). Representative
dot-plot analysis of PBMCs from n-SS control subjects after stimulation with medium (C) or IL-34 (D). Mean percentages
of different monocyte subsets derived from peripheral blood of p-SS patients (E) and n-SS controls (F) after incubation
with rIL-34 or with medium only; results represent the mean ± S.E.M.
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